Vice President, RWE StrategyAetion Germany GmbH, France
Disclosure information not submitted.
Effectiveness and Safety of the MVA-BN vaccine against Mpox in at-risk individuals in the United States (USMVAc)
Wednesday, August 28, 20249:45 AM – 10:00 AM CEST